Metrics-based accountability will get the 340B drug discount program back on track

As I have previously written about in Health Affairs, the 340B drug discount program has taken on a life of its own: this invaluable health care program, originally created to improve the health outcomes of vulnerable patients, has been skewed and misused to enrich hospitals’ profits.

Read the full article on Daily Times Herald here.